Significance of GABAA Receptor for Cognitive Function and Hippocampal Pathology

Int J Mol Sci. 2021 Nov 18;22(22):12456. doi: 10.3390/ijms222212456.

Abstract

The hippocampus is a primary area for contextual memory, known to process spatiotemporal information within a specific episode. Long-term strengthening of glutamatergic transmission is a mechanism of contextual learning in the dorsal cornu ammonis 1 (CA1) area of the hippocampus. CA1-specific immobilization or blockade of α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptor delivery can impair learning performance, indicating a causal relationship between learning and receptor delivery into the synapse. Moreover, contextual learning also strengthens GABAA (gamma-aminobutyric acid) receptor-mediated inhibitory synapses onto CA1 neurons. Recently we revealed that strengthening of GABAA receptor-mediated inhibitory synapses preceded excitatory synaptic plasticity after contextual learning, resulting in a reduced synaptic excitatory/inhibitory (E/I) input balance that returned to pretraining levels within 10 min. The faster plasticity at inhibitory synapses may allow encoding a contextual memory and prevent cognitive dysfunction in various hippocampal pathologies. In this review, we focus on the dynamic changes of GABAA receptor mediated-synaptic currents after contextual learning and the intracellular mechanism underlying rapid inhibitory synaptic plasticity. In addition, we discuss that several pathologies, such as Alzheimer's disease, autism spectrum disorders and epilepsy are characterized by alterations in GABAA receptor trafficking, synaptic E/I imbalance and neuronal excitability.

Keywords: AMPA receptor; GABAA receptor; contextual learning; synaptic plasticity.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Animals
  • Autism Spectrum Disorder / drug therapy
  • Autism Spectrum Disorder / genetics
  • Autism Spectrum Disorder / metabolism*
  • Autism Spectrum Disorder / pathology
  • CA1 Region, Hippocampal / metabolism*
  • CA1 Region, Hippocampal / pathology
  • Cognition / physiology
  • Epilepsy / drug therapy
  • Epilepsy / genetics
  • Epilepsy / metabolism*
  • Epilepsy / pathology
  • Gene Expression Regulation
  • Humans
  • Learning / physiology
  • Neuronal Plasticity / genetics
  • Neurons
  • Nootropic Agents / therapeutic use
  • Protein Transport
  • Receptors, AMPA / genetics*
  • Receptors, AMPA / metabolism
  • Receptors, GABA-A / genetics*
  • Receptors, GABA-A / metabolism
  • Synapses
  • Synaptic Transmission

Substances

  • Nootropic Agents
  • Receptors, AMPA
  • Receptors, GABA-A